Details

here is a real-world need for a shift in engineering philosophy towards disease-specific, outcomes-based technology. This need is so great that we’ve formed strategic partnerships with organizations that are investing millions of dollars in the research and development of diagnostic technologies that can better detect mTBI. To help with this effort, we built Tomorrow's MR, the SIGNA™ Premier, an advanced MR system equipped with innovative coil and gradient technology that directly links to cloud-based analytics. It's the future of MR technology and it's ready today.